Bumper Offer - Urjas oil Just @ Rs. 1
Vomisave 4 Tablet , a prescription drug, is manufactured in various forms such as Tablet. Nausea and Vomiting are some of its major therapeutic uses.
The right dosage of Vomisave 4 Tablet depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Some other side effects of Vomisave 4 Tablet have been listed ahead. Such side effects of Vomisave 4 Tablet normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Vomisave 4 Tablet is Safe for pregnant women and Mild for women who are breastfeeding. Warnings related to Vomisave 4 Tablet 's effects on the liver, heart and kidney, if any, have been listed below.
Vomisave 4 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Heart Disease, Calcium Deficiency, Potassium Deficiency are examples of such conditions. Other contraindications of Vomisave 4 Tablet have been discussed in the sections ahead.
Drug interactions for Vomisave 4 Tablet have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Vomisave 4 Tablet is not safe while driving, and is is not addictive in nature.
Vomisave 4 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Vomisave 4 Tablet is used -
Moderate
Mild
Is the use of Vomisave 4 Tablet safe for pregnant women?
Pregnant women can take Vomisave without worrying about any side effects.
Is the use of Vomisave 4 Tablet safe during breastfeeding?
Side effects of Vomisave for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Vomisave 4 Tablet on the Kidneys?
Vomisave is completely safe for kidneys.
What is the effect of Vomisave 4 Tablet on the Liver?
Vomisave can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Vomisave 4 Tablet on the Heart?
There may be an adverse effect on the heart after taking Vomisave. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
Vomisave 4 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Vomisave 4 Tablet unless your doctor advises you to do so -
Is this Vomisave 4 Tablet habit forming or addictive?
No, there is no any evidence that Vomisave 4 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Vomisave 4 Tablet . So it is best to avoid driving.
Is it safe?
Yes, Vomisave 4 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Vomisave 4 Tablet is not used to treat mental disorders.
Interaction between Food and Vomisave 4 Tablet
You can take Vomisave 4 Tablet with food.
Interaction between Alcohol and Vomisave 4 Tablet
Consult your doctor before consuming alcohol while taking Vomisave 4 Tablet as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 947-948
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 668
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran (ondansetron hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran® (ondansetron hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 947-948
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 668
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran (ondansetron hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran® (ondansetron hydrochloride)
